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Most professional care of skin diseases is provided in physicians’ ofﬁces. In the past 25 y, medical practice has
changed substantially. Since 1973, the National Ambulatory Medical Care Survey has provided data about patients
seen in physicians’ ofﬁces. Using 1974, 1980, and 1989 data, we have previously analyzed these data as they pertain
to skin diseases. To provide a more current assessment of dermatologists’ practices and the care of skin diseases
in ofﬁce-based practice, we analyzed National Ambulatory Medical Care Survey data for 1999 to 2000. We used
statistical methods for survey data to estimate the number and characteristics of visits to dermatologists and
others for skin diseases. We compared the characteristics of dermatologists’ ofﬁce-based practices with those
of other physicians. In 1999 to 2000, there were approximately 35 million visits annually to ofﬁce-based
dermatologists, double the number for 1974. Eight diagnostic groups account for 65% of all visits to
dermatologists. Acne is still the most frequent primary diagnosis at visits to dermatologists, but since 1974 the
proportion of all visits that were for acne has decreased by half. Compared to other ofﬁce-based physicians,
dermatologists are signiﬁcantly more likely to own their practices (OR, 2.78; 95% CI, 1.52–5.02) and much less likely
to see capitated patients (OR, 0.30; 95% CI, 0.17–0.53). Over 26 y, utilization of dermatologists’ services has grown
in proportion to the increase in the number of ofﬁce-based dermatologists. The organization of their practices has
changed little. Dermatologists dominate the care of many of the same diagnoses as they did 20 y ago.
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The resources devoted to caring for skin disease provide
one measure of the burden of skin disease. In the United
States, most care of skin diseases occurs in physicians’
offices. Historically, dermatologists have provided the
majority of care for skin conditions.
Since the 1970s, office-based practice of ambulatory
care in the United States has grown greatly (Delozier and
Gagnon, 1975; Cherry and Woodwell, 2002). In the past
20 y, the number of physicians in office-based nonfederal
ambulatory practice including dermatologists has nearly
doubled, an increase four times greater than the US
population (Infoplease, 2003; U.S. Dept. of Health and
Human Services, 1982, 2002a,b; Ramsay et al, 1984). Since
1980, overall expenditures for health care have more than
tripled. Now totaling more than 1.2 trillion dollars, health-
care expenditures account for 13% of the gross domestic
product (Stanford, 2000). Despite this spending level, nearly
one in three nonelderly Americans was uninsured for all or
part of 2001 to 2002 (Robert Wood Johnson Foundation,
2003). Over the past three decades we have seen the
advent of managed care, diagnostic-related groups, and
the resource-based relative value scale. For many insured
persons, changes in reimbursement have decreased pa-
tients’ out-of-pocket costs for office visits, lowering the
financial barrier to dermatologic care.
In the context of these dramatic changes in health care,
this report details the characteristics of office-based care
now provided by dermatologists and compares the prac-
tices of dermatologists and other office-based physicians.
This report also compares the dermatologists’ practices
now to that described in our prior analyses of the National
Ambulatory Medical Care Surveys, which we first com-
pleted more than 25 years ago (Stern et al, 1977; Stern and
Gardocki, 1986; Stern and Nelson, 1993).
Results
A total of 48,179 sampler visits are included in this analysis.
In 1999 to 2000, the number of visits to office-based
physicians averaged 790 million visits per year. There were
35 million visits each year to office-based dermatologists,
4.4% of all visits. Women account for about 60% of all
ambulatory visits. The proportion of visits to dermatologists
by women was comparable (57%). Patients cared for in
dermatologists’ offices were slightly older, more likely to be
white, and more likely to be seen in nonrural areas (i.e.,
within metropolitan statistical areas) than patients consult-
ing other office-based physicians. The geographic distribu-
tion of office visits to dermatologists was similar to that of
other physicians (Table II).
The care of chronic problems accounted for the majority
of care rendered by dermatologists (Table III). Care ofAbbreviation: NAMCS, National Ambulatory Care Surveys
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chronic disease was significantly more likely to be the
reason for a visit (OR, 2.15; 95% CI, 1.75–2.64) to
dermatologists than other office-based physicians. Visits
to dermatologists’ offices were on average 3 min shorter
than those to other office-based practitioners (po0.01).
This difference is partially attributable to the lower percen-
tage of visits to dermatologists (2.4%) lasting more than 30
min than was the case for other physicians (8%). When only
visits of less than 30 min are considered, visits to
dermatologists average 2.1 min less in duration. (95% CI,
1.2–3.0 min) than was the case for visits to other physicians.
A higher proportion of other physicians’ patients had been
seen in that practice before than was the case for
dermatologists (Table III). Patients referred by another
physician were a significantly higher proportion of derma-
tologists’ practices than that of other physicians (OR, 2.12;
95% CI, 1.49–3.02). One in six visits to dermatologists
required prior insurance authorization, not significantly
different from the proportion for all other office visits.
Dermatologists’ patients were significantly more likely to
have private insurance or be self-paid than patients seeing
other physicians (Table III). Patients seeing other physicians
were four times more likely to have Medicaid compared to
patients seeing dermatologists (OR, 3.97; 95% CI, 2.24–
7.04) (Table III). Patients seeing dermatologists were some-
what more likely to have private insurance than those cared
for by other physicians (OR, 1.33; 95% CI, 1.01–1.73).
Although Health Maintenance Organization members re-
presented comparable numbers of dermatologists’ and
other physicians’ practices, capitated visits were three
times more frequent in other physicians’ practices than was
the case for dermatologists (Table III).
Diagnoses As classified in Table I and presented in Table
IV, we identified eight disease-based diagnostic groups
that together accounted for the majority of first (primary)
diagnosis at visits to dermatologists. In dermatology
practices, acne was the single most frequent diagnosis at
visits to dermatologists and represented about a 100-fold
greater proportion of visits to dermatologists than to other
physicians (OR, 103; 95% CI, 67–156). Seven of the eight
diagnostic groups (i.e., excluding visits for benign skin
lesions) account for 60% of all visits to dermatologists, but
together represent only 1% of all visits to other physicians.
For only two of these eight diagnostic groups (benign
growths and warts) were visits to all other physicians more
frequent than visits to dermatologists. Dermatologists
provided more than half the visits, which included skin
cancer prevention services. Nevertheless, in only about
one-fifth of visits to dermatologists were such preventative
health counseling noted. Only 1% of office visits to other
physicians included this service.
Drug advice For common acne products including iso-
tretinoin, topical retinoids, and minocycline, dermatologists
account for the majority of office visits where use of these
medications was recommended (i.e., recommendation to
use, or continue using, or the prescription of a drug).
Table I. Selected diagnosis groups and associated
ICD9-CM codes
Diagnosis group ICD9-CM code(s)a
Acne 706.1
Rosecea 695.3
Eczema/dermatitis 692.9, 609.1, 691.8
Psoriasis 696.1
Warts 078.1
Skin malignancy 172, 173, 232
Benign skin growths 216.9, 702.1, 706.2, 709.0, 216.5
Actinic keratoses 702.0
V codesb All V codes
aAll analyses as specified were performed on basis of three- or four-
digit ICD9-CM codes.
bRoutine follow-up, general examination.
Table II. Characteristics of patient visits (1999–2000) to dermatologists and all other ofﬁce-based physicians by patient and
practice characteristics (number in millions, %, mean) with 95% CI
Dermatologists All othersa
p valueaN 95% CI N 95% CI
All visits 34 29–39 756 705–810
Percent femaleb (mean) 57 45–60 59 58–60 0.07
Percent whiteb (mean %) 92 91–94 86 84–88 o0.001
Mean ageb (years) 46 45–48 44 43–45 0.007
Geographic region percent distribution
Northeast 20 16–24 23 20–25 0.38
North central 20 13–27 23 19–27
South 32 23–43 31 28–36
West 27 19–35 23 20–26
Percent in metropolitan statistical area 94 88–98 82 77–87 0.003
aAll others¼ all other office-based physicians (see Materials and Methods).
bDermatologist vs. all others.
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Dermatologists were three times more likely to advise
minocycline or doxycycline at visits for acne than other
physicians (Table V). Dermatologists accounted for 38% of
the 2,840,000 visits per year with advice to use very high
potency topical corticosteroids, but less than one-fourth of
visits with advice to use a representative group of less
potent topical corticosteroids (data not shown). Dermatol-
ogists accounted for more than 85% of the 360,000 yearly
visits with advice to use azelaic acid and the 345,000 visits
with advice to use topical 5-fluorouracil. Visits to dermatol-
ogists accounted for over half (60%) of 240,000 visits
with topical calcipitrol use recommended, but less than
one-fifth of the 1,640,000 visits with topical mupirocin use
recommended.
Other aspects of dermatologic care Annually, nearly 12
million visits (34%) to dermatologists include a procedure.
Table III. Characteristics of visits (% distribution) to dermatologists and other physicians, 1999–2000
Type of complaint (% distribution)
Dermatologists Other ofﬁce-based physicians
p valueN 95% CI N 95% CI
Acute 33 28–38 35 34–37 0.34a
Chronic 55 50–59 36 34–37 o0.002a
Postoperative 92 91–94 86 84–88 o0.001a
Mean agea (years) 46 45–48 44 43–45 0.007
Routine care (V codes)
b 60 5–8 20 18–19 o0.002a
Duration of visit (mean), min (excluding visits445 min)a 15 14–16 18 18–19 o0.002
Seen before in practice 79 76–82 88 89–89 o0.002
Referred by other MD 25 20–30 16 15–17 o0.002
Expected primary source of payment
Private insurance 62 57–68 56 54–57 o0.14a
Medicare 21 19–23 20 19–21 40.41a
Self-pay 10 6–15 5 4–6 o0.06a
Medicaid 2 1–3 8 7–9 o0.002a
HMO member 25 20–30 29 27–31 40.15
Capitated visits 4 2–6 12 10–13 o0.002
aCorrected for multiple comparisons.
bSee Table I for definition (includes nonillness care).
Table IV. Number of visits (millions per year) and percent of all
visits by diagnostic groupa and physician type, 1999–2000
Diagnostic group
Dermatologists Other physicians
Number Percentb Number Percentb
Acne 5.15 15.3 1.34 0.2
Rosecea 0.92 2.7 0.18 o 0.1
Eczema 2.76 8.2 4.38 0.6
Psoriasis 0.89 2.6 0.12 o 0.1
Warts 1.94 5.8 2.24 0.2
Skin malignancies 2.06 6.1 1.24 0.2
Benign growths 4.60 13.7 35.70 4.7
Actinic keratosis 5.15 15.3 1.3 0.2
V codes 1.86 5.5 142.1 18.8
Total of above 23.39 69.6 188.6 25
All visits 33.6 100 757 100
aSee Table I for definitions.
bPercent of all visits to specialty.
TableV. Visits with advice to use (thousands per year 
SEM) selected medications by primary diagnosis for
dermatologists and other physicians
Drug
diagnosisa Dermatologists
Other
physicians Total
Isotretinoin
All 948  101 178  76 1125  141
Acne 780  82 >b 863  94
Topical retinoids
All 2772  344 457  201 3228  382
Acne 1817  219 b 2115  263
Minocycline
All 1348  202 350  106 1699  268
Acne 1043  175 b 1159  201
Doxycycline
All 482  131 2286  437 2768  471
Acne 342  117 b 377  124
aPrimary diagnosis for visit.
bEstimates, less than 300,000 not presented owing to imprecision (see
Materials and Methods and Discussion).
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More than 75% of the 3 million office visits, which include a
skin biopsy, occur in dermatologists’ offices.
Dermatologists were significantly more likely than other
office-based physicians to be in solo practice (60% vs.
35%) (OR, 2.82; 95% CI, 2.02–3.93). Nearly 90% of
dermatologists in office-based practice own their practice,
a significantly higher percentage than the other office-
based physicians (OR, 2.78; 95% CI, 1.52–5.02). Dermatol-
ogists were significantly less likely to maintain a laboratory
in their office compared to other physicians (32% vs. 52%)
(OR, 0.43; 95% CI, 0.29–0.63). Nurse practitioners pro-
vide less than 1% of care in a dermatologist’s office, a
significantly lower proportion than observed in other types
of offices (OR, 0.10; 95% CI, 0.03–0.33).
Follow-up planning for patients visiting dermatologists and
other physicians did not differ significantly. In dermatology
practices, 65% of patients were asked to return at a specific
time and an additional 25% were asked to return as needed.
Discussion
Utilization of health services The NAMCS is a federal
survey of office-based practice (Cherry and Woodwell,
2002). Since its initiation in 1973, this survey provides data
that permits quantification of the nature of visits to office-
based physicians (Delozier and Gagnon, 1975). Since our
initial 1974 analysis of dermatologic data from this survey,
we have periodically reanalyzed these surveys, which were
conducted periodically from 1973 to 1989 and annually
since that year (Stern, 1977, 1993; Stern and Gardocki,
1986). Taken together with prior results, the analysis of the
most recent available surveys provides more than 25 years
perspective on the quantity and content of office-based
dermatologic care.
From 1974 to 2000, the number of visits to dermatolo-
gists in office-based practice nearly doubled from 18 million
to 35 million per year, a far greater increase than for total
visits for office-based care, which increased from 635
million to 752 million annually during this time period (20%).
During this interval, the number of dermatologists in office-
based practice approximately doubled (Ramsay et al, 1984).
Each office-based dermatologist sees an average about
5000 patients per year. In the past 20 years, the average
duration of a visit to a dermatologist has, however,
increased more than 25% (Stern and Gardocki, 1986).
Demographic characteristics More detailed information
on the demographic characteristics of patients, physician
diagnoses and therapeutic services have been available for
dermatology than was the case for our first analysis of 1974
data. Both over time and compared to visits to other
physicians, the female predominance among those visiting
dermatologists has been remarkably consistent. Women
represent approximately 60% of all visits to dermatologists
and other office practitioners. Since 1980, the absolute
increase in the percent of visits by nonwhite persons, from
10 to 14% for other physicians and from 5 to 8% for
dermatologists, has been comparable. Nevertheless, the
proportion of nonwhite persons seen in dermatologists’
offices continues to be only about half the proportion of
visits by nonwhite persons to other office-based physicians.
Over time, the age distribution of patients’ visits to
dermatologists has changed significantly. Twenty years ago,
patients under age 30 accounted for about half of visits to
dermatologists. Now this group accounts for only about
one-fourth of visits to dermatologists. Over these two
decades the proportion of visits to dermatologists by
patients age 45 to 64 y has increased 50%, and the
proportion of visits by patients age 65 or older has doubled.
Visits by older Americans have risen far more than can be
accounted for by the aging of the US population.
Dermatologists’ practices Dermatologists’ practices sub-
stantially differ from that of other office-based physicians in
organizational and financial aspects as well as content.
Dermatologists provide only about one-third the proportion
of their services outside metropolitan statistical areas (i.e.,
nonrural areas) as do other physicians. Dermatologists see
a higher proportion of self-pay and privately insured
patients than other physicians. The proportions of Medicaid
and capitated visits in dermatologists’ practices is one-third
or less the proportion in other physicians’ practices.
Patients referred by another physician and new patients
are now about twice as frequent in dermatologists than
other physicians’ practices, a finding similar to that of more
than 25 y ago (Stern, 1977).
Reasons for visits The eight diagnostic groups detailed in
Table I compose the principle reason for nearly two-thirds of
all visits to dermatologists. Acne is still the most frequent
diagnosis at visits to dermatologists. Nevertheless, com-
pared to 1980, acne now accounts for only about half the
fraction of all visits to dermatologists as it did then. Since
1980 the number of visits to nondermatologists for acne has
increased more than fourfold, but dermatologist still provide
nearly 80% of visits for acne.
Over this 20-y period, visits to dermatologists for skin
malignancies have increased by about two-thirds (Stern,
1986). Dermatologists provide skin cancer prevention
counseling to nearly one-fourth of their patients, but other
physicians do so very infrequently (about 1%).
Although common in the general population, psoriasis
continues to account for only about 1 million visits per year
(Lebwohl, 2003). Dermatologists no longer account for the
majority of visits for warts, but the proportions of visits to
dermatologists for many other skin diagnoses including
eczema and acne is relatively unchanged over the past two
decades. After acne and benign growths, actinic keratoses
is the third most frequent primary diagnosis for visits to
dermatologists. Dermatologists’ office practices are proce-
durally oriented. One in three visits to a dermatologist
includes a procedure, and dermatologists provide 60% of
all office-based skin procedures.
Recommendations of drug therapy The distribution of
drugs recommended at visits for acne to dermatologists
illustrates the importance of a relatively few agents in the
treatment of this disease. Topical retinoids are dispensed at
one-third of acne visits and isotretinoin is prescribed nearly
half as often as are tetracyclines at visits for acne. Very high
potency steroids are recommended twice as often now
compared to 10 y ago. In marked contrast to a decade ago
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when dermatologists accounted for more than three-fourths
of all very high potency recommendations, now other
physicians account for the majority of visits with a very high
potency topical corticosteroid recommended (Stern, 1996).
Strengths and limitations The strengths of this study
include the design of the NAMCS, which scientifically
samples a large number of office-based practioners; the high
rate of participation among these sampled; and its estab-
lished methodology and trained staff. As in the case for
estimates derived from any sample, estimates from the survey
are subject to error. Nevertheless, the design of the survey
and the specialized statistical methods available for analysis
permitted us to calculate standard errors and confidence
intervals for the estimates. Although our analysis included
data from nearly 50,000 sampled visits, estimates of less than
300,000 visits to dermatologists are subject to substantial
error (i.e., relative standard error430%) and are not provided.
This limits our analysis to common diagnoses and draws
relatively broad categorizations of patient characteristics.
The doubling of visits to dermatologists’ in the past 25 y
is testimony to the substantial burden of skin disease in the
United States. This parallel rate of growth in the number of
dermatologists and utilization of their services suggests
that, so far, supply rather than need or demand is the
primary determinant of the expert resources devoted to the
care of skin disease in the United States (Stern, 1986).
Materials and Methods
We analyzed data from the 1999 and 2000 National Ambulatory Care
Surveys (NAMCS). This federal survey samples physicians in office-
based practices and patient visits within these practices (U.S. Dept. of
Health and Human Services, 2001, 2002a, b). It utilizes a multistage
probability sample to select the physicians’ practices to be studied.
These practices are selected for participation based on master files
maintained by the American Medical Association and the American
Medical Osteopathic Association, which includes all US physicians.
The sample for the NAMCS is restricted to physicians who primarily
provide patient care in office-based practices and were not federally
employed. They number more than 430,000. The survey excludes
radiologists, pathologists, and anesthesiologists. In 1999 to 2000, 3777
physicians were asked to participate and 2475 (66%) participated. A
total of 134 of 209 (64%) sampled dermatologists participated, who
comprise 2% of dermatologists in office-based care. Each sampled
physician was randomly assigned 1 of 52 wk of the year to record the
characteristics of a sample (of 20%–100%) of all patients seen during
that week (U.S. Dept. of Health and Human Services 2001, 2002a, b).
Among the data collected are physicians’ specialty, location, and for
each visit during the sample period demographic and disease
characteristics of the patient including the principle diagnosis associated
with the visit and medications prescribed and disposition for the visit.
Statistical methods Because of its use of a multistage sampling,
the survey is able to utilize four statistical techniques: (1) inflation
by reciprocals, (2) adjustment for nonresponse, (3) a ratio
adjustment to fixed totals, and (4) weights. As a result survey data
can be used to calculate unbiased national estimates of the
number of visits with given characteristics (U.S. Dept. of Health
and Human Services, 2002a, b). These attributes of the design of
the NAMCS permit the calculation of sample weights for each
observation and define the cluster (population sample unit) and
strateum for each sampled visit. Sample weights permit calculation
of point estimates. In the case of the NAMCS, sample weights,
cluster (population sample unit) strateum, are provided for each
observation. The design permits use of specialized statistical
programs for surveys. We used these programs to calculate the
standard error (SE) of point estimates, odds ratios (OR), and 95%
confidence intervals (95% CI) (Stata Press, 2003). We used the
Bonferroni method to correct for multiple comparisons.
Diagnostic and drug categories We tabulated the most fre-
quently cited diagnoses seen in dermatologists’ practices and we
grouped these ICD9-CM diagnosis codes according to the
classification schema presented in Table I. This classification closely
parallels the one we utilized in analyzes of data from earlier survey
years (U.S. Dept. of Health and Human Services, 2002a, b; Stern,
1986). We also quantified visits with a recommendation to use
prescriptions for specific medications, which have been the focus of
our prior analyses. These include topical retinoids, isotretinoin, and
tetracyclines as well as selected other prescription agents which are
widely promoted for dermatologic use (Stern, 1994, 1996).
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